TIDMCRDA

RNS Number : 9799V

Croda International PLC

13 August 2020

Press Release

13 August 2020

Croda completes acquisition of Avanti Polar Lipids

Croda International Plc ('Croda') today confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

For further information see the announcement of the acquisition signing dated 6 July 2020.

About Croda:

Croda is the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally. More at www.croda.com .

Further information:

   Investors: David Bishop, Croda                                              +44 7823 874428 
   Media: Charlie Armitstead, Teneo                                          +44 7703 330269

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACQEAXPAFLPEEFA

(END) Dow Jones Newswires

August 13, 2020 02:00 ET (06:00 GMT)

Grafico Azioni Croda (LSE:CRDA)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Croda
Grafico Azioni Croda (LSE:CRDA)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Croda